Revance Therapeutics, Inc. Contracts & Agreements

148 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 1.75% Convertible Senior Notes Due 2027 between Revance Therapeutics, Inc. and U.S. Bank Trust Company, N.A.
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Amendment No. 2 to Amended and Restated Agreement and Plan of Merger among Crown Laboratories, Reba Merger Sub, and Revance Therapeutics
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2025
Amendment to Amended and Restated Agreement and Plan of Merger among Crown Laboratories, Reba Merger Sub, and Revance Therapeutics
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Amended and Restated Agreement and Plan of Merger among Crown Laboratories, Inc., Reba Merger Sub, Inc., and Revance Therapeutics, Inc.
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2024
Amended and Restated Tender and Support Agreement among Crown Laboratories, Inc., Reba Merger Sub, Inc., and Stockholders of Revance Therapeutics, Inc.
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2024
Fourth Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Fifth Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc. (July 29, 2024)
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Sixth Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Exclusive Distribution Agreement between Revance Therapeutics, Inc., Revance Australia Pty. Ltd., and Teoxane SA
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2024
Agreement and Plan of Merger among Crown Laboratories, Inc., Reba Merger Sub, Inc., and Revance Therapeutics, Inc. (August 11, 2024)
Merger Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2024
Revance Therapeutics Chief Medical Officer Employment Offer Letter to David A. Hollander, MD
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Employment Offer Letter for Senior Vice President, Strategy – Erica Jordan
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Effective April 25, 2024)
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Barclays Capital Inc., March 2024
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Description of Revance Therapeutics, Inc. Common and Preferred Stock
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Revance Therapeutics, Inc. 2024 Management Bonus Program
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Amendment No. 2 to Technology Transfer, Validation and Commercial Fill/Finish Services Agreement between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc.
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2024
Separation Agreement between Revance Therapeutics, Inc. and Dustin S. Sjuts
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2024
Revance Therapeutics, Inc. Executive Severance Benefit Plan (Amended and Restated as of February 7, 2024)
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2024
License and Service Agreement between Revance Therapeutics, Inc. and List Biological Laboratories, Inc.
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2023
First Addendum to License and Service Agreement between Revance Therapeutics, Inc. and List Biological Laboratories, Inc.
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Third Amendment to Lease Agreement between 1222 Demonbreun, LP and Revance Therapeutics, Inc.
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Second Letter Amendment to License Agreement between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2023
Third Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Second Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Underwriting Agreement between Revance Therapeutics, Inc. and Underwriters (Goldman Sachs, Cowen, Guggenheim) for Common Stock Offering
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Third Addendum to License and Service Agreement between Revance Therapeutics, Inc. and List E, LLC
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Note Purchase Agreement among Revance Therapeutics, Inc., Certain Subsidiaries, Athyrium Buffalo LP, and Purchasers (March 18, 2022)
Note Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2022
Description of Revance Therapeutics, Inc. Common Stock
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Second Amendment to Lease Agreement between 1222 Demonbreun, LP and Revance Therapeutics, Inc.
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Second Addendum to License and Service Agreement between Revance Therapeutics, Inc. and List Biological Laboratories, Inc.
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Amendment to Office Lease Agreement between 1222 Demonbreun, LP and Revance Therapeutics, Inc. (January 4, 2021)
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Amendment No. 1 to Technology Transfer, Validation and Commercial Fill/Finish Services Agreement between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Letter Amendment to License Agreement between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd.
Modification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Office Lease Agreement between 1222 Demonbreun, LP and Revance Therapeutics, Inc. for 1222 Demonbreun, Nashville, TN
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
TN
2020
Employment Agreement between Revance Therapeutics, Inc. and Aubrey Rankin
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
First Amendment to Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc.
Modification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Fifth Amendment to Lease Agreement between BMR-Pacific Research Center LP and Revance Therapeutics, Inc.
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Loan Agreement between Revance Therapeutics, Inc. and Hint, Inc. dated May 18, 2020
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Description of Revance Therapeutics, Inc. Common Stock Registered under Section 12 of the Exchange Act
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Executive Employment Agreement between Revance Therapeutics, Inc. and Dustin Sjuts
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Executive Employment Agreement between Revance Therapeutics, Inc. and Dwight Moxie
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Indenture for 1.75% Convertible Senior Notes due 2027 between Revance Therapeutics, Inc. and U.S. Bank National Association
Indenture Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Cowen, Piper Jaffray, and Stifel (December 2019)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Executive Severance Benefit Plan (Amended and Restated October 13, 2019)
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Executive Employment Agreement between Revance Therapeutics, Inc. and Mark Foley
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. Executive Severance Benefit Plan (Amended and Restated February 12, 2019)
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Revance Therapeutics, Inc. 2019 Management Bonus Program for Executive Officers
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Executive Employment Agreement between Revance Therapeutics, Inc. and Tobin Schilke
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
License Agreement between Revance Therapeutics, Inc. and Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. (December 4, 2018)
License Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2019
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs, Cowen, and Piper Jaffray (2019)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Executive Employment Agreement between Revance Therapeutics, Inc. and Caryn G. McDowell, Effective May 1, 2018
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2018
Fourth Amendment to Lease Agreement between BMR-Pacific Research Center LP and Revance Therapeutics, Inc.
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Revance Therapeutics, Inc. Third Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2018
Revance Therapeutics, Inc. 2018 Management Bonus Program for Executive Officers
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Revance Therapeutics, Inc. Common Stock Underwriting Agreement with Goldman Sachs & Co. LLC and Cowen and Company, LLC (December 6, 2017)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2017
Executive Employment Agreement between Revance Therapeutics, Inc. and Todd Zavodnick
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
Revance Therapeutics, Inc. Second Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
Common Stock Sales Agreement between Revance Therapeutics, Inc. and Cowen and Company, LLC (March 7, 2016)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2016
Revance Therapeutics, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2016
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Effective January 1, 2016)
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
Executive Employment Agreement between Revance Therapeutics, Inc. and Abhay Joshi, PhD, MBA
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2016
Revance Therapeutics, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2015
Revance Therapeutics, Inc. Stock Option Grant Notice and Option Agreement (2014 Equity Incentive Plan)
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. 2014 Inducement Plan Stock Option Grant Notice and Option Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Underwriting Agreement with Cowen and Company, LLC and Piper Jaffray & Co. (November 3, 2015)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
Revance Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Amended and Restated Executive Severance Benefit Plan
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
Second Amendment to Loan and Lease Agreement between Essex Capital Corporation and Revance Therapeutics, Inc.
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Warrant to Purchase Capital Stock between Revance Therapeutics, Inc. and Essex Capital Corporation (December 20, 2014)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2015
Common Stock Sales Agreement between Revance Therapeutics, Inc. and Cowen and Company, LLC (March 4, 2015)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2015
First Amendment to Loan and Lease Agreement between Essex Capital Corporation and Revance Therapeutics, Inc.
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Executive Employment Agreement between Revance Therapeutics, Inc. and Arthur P. Bertolino
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. 2014 Inducement Plan Stock Option Grant Notice and Option Agreement
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Revance Therapeutics, Inc. 2014 Inducement Plan Restricted Stock Grant Agreement with Participant
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Underwriting Agreement between Revance Therapeutics, Inc. and Underwriters (Cowen and Company, LLC, Piper Jaffray & Co.)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
Revance Therapeutics, Inc. 2014 Equity Incentive Plan Restricted Stock Unit Award Agreement
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
Revance Therapeutics, Inc. Director Appointment Letter Agreement with Angus C. Russell (March 2014)
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Third Amendment to Lease Agreement between BMR-Gateway Boulevard LLC and Revance Therapeutics, Inc.
Lease Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Revance Therapeutics, Inc. Common Stock Certificate
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Second Amendment to Loan and Security Agreement between Revance Therapeutics, Inc. and Hercules Technology Growth Capital, Inc.
Loan Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
Revance Therapeutics, Inc. Non-Employee Director Compensation Policy
Compensation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Executive Employment Agreement between Revance Therapeutics, Inc. and L. Daniel Browne
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Executive Employment Agreement between Revance Therapeutics, Inc. and Jacob Waugh, M.D.
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Executive Employment Agreement between Revance Therapeutics, Inc. and Lauren Silvernail
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Executive Employment Agreement between Revance Therapeutics, Inc. and Curtis Ruegg, Ph.D.
Employment Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Series Preferred Stock between Revance Therapeutics, Inc. and Holder
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant Agreement to Purchase Series D Preferred Stock between Revance Therapeutics, Inc. and Essex Capital Corporation (June 2010)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Capital Stock between Revance Therapeutics, Inc. and Essex Capital Corporation
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant to Purchase Series Preferred Stock between Revance Therapeutics, Inc. and Holder
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Warrant Agreement to Purchase Preferred Stock between ReVance Therapeutics, Inc. and Hercules Technology Growth Capital, Inc.
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. 2002 Equity Incentive Plan (as Amended and Restated)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
Revance Therapeutics, Inc. Amended and Restated 2012 Equity Incentive Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2013
Revance Therapeutics, Inc. 2023 Management Bonus Program
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2023
Separation and Consulting Agreement between Revance Therapeutics, Inc. and Dr. Abhay Joshi
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Revance Therapeutics, Inc. 2022 Management Bonus Program
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2022
Technology Transfer, Validation, and Commercial Fill/Finish Services Agreement between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc.
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Separation and Consulting Agreement between Revance Therapeutics, Inc. and Aubrey Rankin
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2022
Commercial Supply Agreement between Revance Therapeutics, Inc. and Lyophilization Services of New England, Inc.
Supply Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2021
Revance Therapeutics, Inc. Restricted Stock Bonus Grant Notice and Agreement (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2021
Revance Therapeutics, Inc. 2021 Management Bonus Program Agreement
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2021
Revance Therapeutics, Inc. Amended and Restated 2014 Inducement Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Voting Agreement between Revance Therapeutics, Inc. and Stockholder Regarding Merger with Hint, Inc.
Voting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2020
Lock-Up Agreement between Revance Therapeutics, Inc. and Stockholder Regarding Merger with Hint, Inc.
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Revance Therapeutics, Inc. 2020 Management Bonus Program Agreement
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Separation Agreement between Revance Therapeutics, Inc. and Caryn G. McDowell
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2020
Exclusive Distribution Agreement between Teoxane SA and Revance Therapeutics Inc. dated January 10, 2020
Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2020
Amendment No. 1 to Collaboration and License Agreement between Revance Therapeutics, Inc. and Mylan Ireland Ltd.
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2019
Separation Agreement between Revance Therapeutics, Inc. and L. Daniel Browne
Separation Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2019
First Amendment to Manufacture and Development Agreement between Bachem Americas, Inc. and Revance Therapeutics, Inc.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2018
Collaboration and License Agreement between Mylan Ireland Ltd. and Revance Therapeutics, Inc. (February 28, 2018)
Collaboration Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2018
Technology Transfer, Validation, and Commercial Fill/Finish Services Agreement between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc.
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2017
Revance Therapeutics, Inc. 2017 Management Bonus Program for Executive Officers
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2017
Revance Therapeutics, Inc. Restricted Stock Bonus Grant Notice and Agreement (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
Revance Therapeutics, Inc. 2016 Management Bonus Program
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2016
Second Amendment to Development and Supply Agreement between Revance Therapeutics, Inc. and Hospira Worldwide, Inc.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Restricted Stock Bonus Agreement (2014 Equity Incentive Plan)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. Director Appointment and Compensation Agreement with Philip J. Vickers
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
First Amendment to Development, Manufacturing and Supply Agreement between Duoject Medical Systems Inc. and Revance Therapeutics, Inc.
Development Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2015
Revance Therapeutics, Inc. 2014 Inducement Plan (as Amended)
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. 2014 Inducement Plan
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. Director and Audit Committee Chair Appointment Agreement with Mark Prygocki
Services Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Revance Therapeutics, Inc. 2014 Management Bonus Program for Executive Officers
Bonus & Incentive Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Underwriting Agreement between Revance Therapeutics, Inc. and Underwriters (Cowen and Company, LLC, Piper Jaffray & Co.)
Underwriting Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
NY
2014
Amended and Restated Investor Rights Agreement between Revance Therapeutics, Inc. and Investors
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. 2014 Equity Incentive Plan
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Revance Therapeutics, Inc. Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan)
Equity Distribution Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
Revance Therapeutics, Inc. 2014 Employee Stock Purchase Plan
Stock Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2014
Indemnity Agreement between Revance Therapeutics, Inc. and Officer or Director
Indemnification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2014
Revance Therapeutics, Inc. Warrant to Purchase Common Stock Agreement (December 6, 2012)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2014
Amended and Restated Investor Rights Agreement between Revance Therapeutics, Inc. and Investors (March 29, 2013)
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
Amendment No. 1 to Amended and Restated Investor Rights Agreement by Revance Therapeutics, Inc. and Investors
Investor Rights Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2013
Revance Therapeutics, Inc. Stock Option Grant Notice and Agreement (2002 Equity Incentive Plan)
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
2013
Revance Therapeutics, Inc. Stock Option Grant Notice under Amended and Restated 2012 Equity Incentive Plan
Warrant Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2013
Indemnity Agreement between Revance Therapeutics, Inc. and Indemnitee
Indemnification Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
DE
2013